Epilepsy
A novel potassium channel opener was well-tolerated and reduced seizures in patients with focal-onset seizures.
In the phase 2 ARCADE trial, soticlestat reduced motor seizure frequency in CDD but increased it in Dup15q syndrome.
Authors noted that approximately 20% to 40% of patients with generalized convulsive status epilepticus (GCSE) have ...
A study identified alterations in patients with juvenile myoclonic epilepsy (JME) compared to healthy patients. The ...
The monitoring of ictal semiology signs in temporal lobe epilepsy (TLE) and temporal plus epilepsy (TPE) is mission ...
A systematic review published in Clinical Rehabilitation found low-to-moderate quality evidence that yoga helped improve ...
Advertisement
Expert Interviews on Epilepsy
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.